✦ LIBER ✦

DOP059 Reduction of fecal calprotectin levels and relationship to clinical parameters in the phase 2 study of laquinimod for the treatment of active moderate to severe Crohn's disease

✍ Scribed by D'Haens, G.; Sandborn, W.J.; Rutgeerts, P.; Colombel, J.F.; Brown, K.; Haviv, A.; Barkay, H.; Sakov, A.; Feagan, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1085 Reduction of Fecal Calprotectin a

✍ D'Haens, Geert R.; Sandborn, William; Colombel, Jean-Frederic; Brown, Kurt; Havi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 861 KB

Sa1212 Relationship Between Adalimumab C

✍ Sharma, Shringi; Pradhan, Rajendra S.; Thakkar, Roopal; Robinson, Anne; Hyams, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 388 KB

P384 Relationship between adalimumab con

✍ Sharma, S.; Pradhan, R.; Thakkar, R.; Robinson, A.; Hyams, J.; Rosh, J.; Ruemmel 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 107 KB

Sa1210 Relationship Between Adalimumab C

✍ Pradhan, Rajendra S.; Sharma, Shringi; Thakkar, Roopal; Robinson, Anne; Hyams, J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 473 KB

P385 Relationship between adalimumab con

✍ Pradhan, R.; Sharma, S.; Thakkar, R.; Robinson, A.; Hyams, J.; Rosh, J.; Ruemmel 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 116 KB

Clinical trial: the effects of certolizu

✍ B. G. FEAGAN; M. C. REILLY; L. GERLIER; Y. BRABANT; M. BROWN; S. SCHREIBER 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB